Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Stockholders' Equity (Details) - Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range

v3.8.0.1
Note 11 - Stockholders' Equity (Details) - Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range - $ / shares
 6 Months Ended 12 Months Ended
Nov. 30, 2017
May 31, 2017
Note 11 - Stockholders' Equity (Details) - Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Line Items]    
Number of warrants outstanding (in Shares) 350,000 0
Weighted average remaining contractual life 2 years 350 days  
Weighted average exercise price of outstanding warrants $ 0.75 $ 0
Number of warrants exerciable (in Shares) 350,000  
Weighted average exercise price of exerciable warrants $ 0.75  
Warrants Exerciable at $0.75 [Member]    
Note 11 - Stockholders' Equity (Details) - Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Line Items]    
Exercise Price $ 0.75  
Number of warrants outstanding (in Shares) 350,000  
Weighted average remaining contractual life 2 years 350 days  
Weighted average exercise price of outstanding warrants $ 0.75  
Number of warrants exerciable (in Shares) 350,000  
Weighted average exercise price of exerciable warrants $ 0.75